Correlation Between Oakley Capital and Cizzle Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oakley Capital and Cizzle Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oakley Capital and Cizzle Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oakley Capital Investments and Cizzle Biotechnology Holdings, you can compare the effects of market volatilities on Oakley Capital and Cizzle Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oakley Capital with a short position of Cizzle Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oakley Capital and Cizzle Biotechnology.

Diversification Opportunities for Oakley Capital and Cizzle Biotechnology

0.14
  Correlation Coefficient

Average diversification

The 3 months correlation between Oakley and Cizzle is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Oakley Capital Investments and Cizzle Biotechnology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cizzle Biotechnology and Oakley Capital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oakley Capital Investments are associated (or correlated) with Cizzle Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cizzle Biotechnology has no effect on the direction of Oakley Capital i.e., Oakley Capital and Cizzle Biotechnology go up and down completely randomly.

Pair Corralation between Oakley Capital and Cizzle Biotechnology

Assuming the 90 days trading horizon Oakley Capital is expected to generate 2.81 times less return on investment than Cizzle Biotechnology. But when comparing it to its historical volatility, Oakley Capital Investments is 4.12 times less risky than Cizzle Biotechnology. It trades about 0.03 of its potential returns per unit of risk. Cizzle Biotechnology Holdings is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  155.00  in Cizzle Biotechnology Holdings on October 4, 2024 and sell it today you would earn a total of  0.00  from holding Cizzle Biotechnology Holdings or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Oakley Capital Investments  vs.  Cizzle Biotechnology Holdings

 Performance 
       Timeline  
Oakley Capital Inves 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oakley Capital Investments has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Oakley Capital is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.
Cizzle Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cizzle Biotechnology Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Oakley Capital and Cizzle Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oakley Capital and Cizzle Biotechnology

The main advantage of trading using opposite Oakley Capital and Cizzle Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oakley Capital position performs unexpectedly, Cizzle Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cizzle Biotechnology will offset losses from the drop in Cizzle Biotechnology's long position.
The idea behind Oakley Capital Investments and Cizzle Biotechnology Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets